---
title: "AbbVie: Competitors & Industry Structure"
description: "AbbVie compared with companies that share its SEC industry classification: revenue, growth and margins from SEC filings, and how the peer group is chosen."
canonical: https://www.getswoopr.com/stocks/companies/abbvie/competitors/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# AbbVie: Competitors & Industry Structure



## Direct Answer

SEC EDGAR classifies AbbVie under SIC code 2834 (Pharmaceutical Preparations). Among Swoopr's S&P 500 Equal Weight companies, 231 others share that classification; by latest reported revenue, AbbVie ranks 4 of 232. A filing classification is a starting point: a company's real competitors depend on its segments, which its 10-K describes.

## How Does AbbVie Compare With Its Peers?

| Company | Revenue (latest FY) | Revenue growth | Operating margin | Net margin |
| --- | --- | --- | --- | --- |
| [Johnson & Johnson (JNJ)](https://www.getswoopr.com/stocks/companies/johnson-and-johnson/) | $94.2 billion FY2025 | 6.0% | n/a | 28.5% |
| [Eli Lilly (LLY)](https://www.getswoopr.com/stocks/companies/eli-lilly/) | $65.2 billion FY2025 | 44.7% | n/a | 31.7% |
| [Pfizer (PFE)](https://www.getswoopr.com/stocks/companies/pfizer/) | $62.6 billion FY2025 | -1.6% | n/a | 12.4% |
| **AbbVie (ABBV)** | $61.2 billion FY2025 | 8.6% | 24.6% | 6.9% |
| [Bristol Myers Squibb (BMY)](https://www.getswoopr.com/stocks/companies/bristol-myers-squibb/) | $48.2 billion FY2025 | -0.2% | n/a | 14.6% |
| [Abbott Laboratories (ABT)](https://www.getswoopr.com/stocks/companies/abbott-laboratories/) | $44.3 billion FY2025 | 5.7% | 18.2% | 14.7% |
| [Viatris (VTRS)](https://www.getswoopr.com/stocks/companies/viatris/) | $14.3 billion FY2025 | -3.0% | -18.6% | -24.6% |
| [Vertex Pharmaceuticals (VRTX)](https://www.getswoopr.com/stocks/companies/vertex-pharmaceuticals/) | $12.0 billion FY2025 | 8.9% | 34.8% | 32.9% |
| [Zoetis (ZTS)](https://www.getswoopr.com/stocks/companies/zoetis/) | $9.5 billion FY2025 | 2.3% | n/a | 28.2% |
| [Organon & Co. (OGN)](https://www.getswoopr.com/stocks/companies/organon-and-co/) | $6.2 billion FY2025 | -2.9% | n/a | 3.0% |
| [Elanco Animal Health Incorporated (ELAN)](https://www.getswoopr.com/stocks/companies/elanco-animal-health-incorporated/) | $4.7 billion FY2025 | 6.2% | n/a | -4.9% |
| [Alnylam Pharmaceuticals (ALNY)](https://www.getswoopr.com/stocks/companies/alnylam-pharmaceuticals/) | $3.7 billion FY2025 | 65.2% | 13.5% | 8.4% |
| [BioMarin Pharmaceutical Inc. (BMRN)](https://www.getswoopr.com/stocks/companies/biomarin-pharmaceutical-inc/) | $3.2 billion FY2025 | 12.9% | 12.7% | 10.8% |
| [United Therapeutics Corporation (UTHR)](https://www.getswoopr.com/stocks/companies/united-therapeutics-corporation/) | $3.2 billion FY2025 | 10.6% | 46.9% | 41.9% |
| [Royalty Pharma plc (RPRX)](https://www.getswoopr.com/stocks/companies/royalty-pharma-plc/) | $2.4 billion FY2025 | 5.1% | 65.6% | 32.4% |
| [Madrigal Pharmaceuticals Inc. (MDGL)](https://www.getswoopr.com/stocks/companies/madrigal-pharmaceuticals-inc/) | $958 million FY2025 | 432.1% | -31.3% | -30.1% |
| [Ionis Pharmaceuticals Inc. (IONS)](https://www.getswoopr.com/stocks/companies/ionis-pharmaceuticals-inc/) | $944 million FY2025 | 33.8% | -40.4% | -40.4% |
| [Arrowhead Pharmaceuticals Inc. (ARWR)](https://www.getswoopr.com/stocks/companies/arrowhead-pharmaceuticals-inc/) | $829 million FY2025 | 23258.2% | 11.9% | -0.2% |
| [Corcept Therapeutics Incorporated (CORT)](https://www.getswoopr.com/stocks/companies/corcept-therapeutics-incorporated/) | $761 million FY2025 | 12.8% | 5.9% | 13.1% |
| [Emergent BioSolutions Inc. (EBS)](https://www.getswoopr.com/stocks/companies/emergent-biosolutions-inc/) | $743 million FY2025 | -28.8% | 13.5% | 7.1% |
| [Kiniksa Pharmaceuticals International plc (KNSA)](https://www.getswoopr.com/stocks/companies/kiniksa-pharmaceuticals-international-plc/) | $678 million FY2025 | 60.1% | 11.4% | 8.7% |
| [Ultragenyx Pharmaceutical Inc. (RARE)](https://www.getswoopr.com/stocks/companies/ultragenyx-pharmaceutical-inc/) | $673 million FY2025 | 20.2% | -79.5% | -85.4% |
| [Axsome Therapeutics Inc. (AXSM)](https://www.getswoopr.com/stocks/companies/axsome-therapeutics-inc/) | $638 million FY2025 | 65.5% | -26.1% | -28.7% |
| [OPKO Health Inc. (OPK)](https://www.getswoopr.com/stocks/companies/opko-health-inc/) | $607 million FY2025 | -14.9% | -19.3% | -37187.0% |
| [Insmed Incorporated (INSM)](https://www.getswoopr.com/stocks/companies/insmed-incorporated/) | $606 million FY2025 | 66.7% | -205.6% | -210.5% |
| [Organogenesis Holdings Inc. (ORGO)](https://www.getswoopr.com/stocks/companies/organogenesis-holdings-inc/) | $564 million FY2025 | 17.0% | 7.9% | 6.6% |
| [Mirum Pharmaceuticals Inc. (MIRM)](https://www.getswoopr.com/stocks/companies/mirum-pharmaceuticals-inc/) | $521 million FY2025 | 54.7% | -4.2% | -4.5% |
| [BridgeBio Pharma Inc. (BBIO)](https://www.getswoopr.com/stocks/companies/bridgebio-pharma-inc/) | $502 million FY2025 | 126.3% | -104.2% | -146.0% |
| [Travere Therapeutics Inc. (TVTX)](https://www.getswoopr.com/stocks/companies/travere-therapeutics-inc/) | $491 million FY2025 | 110.5% | -12.8% | -5.2% |
| [Nature's Sunshine Products Inc. (NATR)](https://www.getswoopr.com/stocks/companies/natures-sunshine-products-inc/) | $480 million FY2025 | 5.7% | 5.2% | 4.1% |
| [Ardelyx Inc. (ARDX)](https://www.getswoopr.com/stocks/companies/ardelyx-inc/) | $407 million FY2025 | 22.1% | -10.1% | -15.2% |
| [Arcutis Biotherapeutics Inc. (ARQT)](https://www.getswoopr.com/stocks/companies/arcutis-biotherapeutics-inc/) | $376 million FY2025 | 91.3% | -3.3% | -4.3% |
| [MannKind Corporation (MNKD)](https://www.getswoopr.com/stocks/companies/mannkind-corporation/) | $349 million FY2025 | 22.2% | 11.1% | 1.7% |
| [CorMedix Inc. (CRMD)](https://www.getswoopr.com/stocks/companies/cormedix-inc/) | $312 million FY2025 | 617.0% | 48.2% | 52.3% |
| [Evolus Inc. (EOLS)](https://www.getswoopr.com/stocks/companies/evolus-inc/) | $297 million FY2025 | 11.6% | -11.0% | -17.4% |
| [Ironwood Pharmaceuticals Inc. (IRWD)](https://www.getswoopr.com/stocks/companies/ironwood-pharmaceuticals-inc/) | $296 million FY2025 | -15.7% | 33.3% | 8.1% |
| [Rigel Pharmaceuticals Inc. (RIGL)](https://www.getswoopr.com/stocks/companies/rigel-pharmaceuticals-inc/) | $294 million FY2025 | 64.1% | 42.6% | 124.7% |
| [Xeris Biopharma Holdings Inc. (XERS)](https://www.getswoopr.com/stocks/companies/xeris-biopharma-holdings-inc/) | $292 million FY2025 | 43.7% | 8.5% | 0.2% |
| [Harrow Inc. (HROW)](https://www.getswoopr.com/stocks/companies/harrow-inc/) | $272 million FY2025 | 36.4% | 11.2% | -1.9% |
| [Arvinas Inc. (ARVN)](https://www.getswoopr.com/stocks/companies/arvinas-inc/) | $263 million FY2025 | -0.3% | -45.1% | -30.8% |
| [Keros Therapeutics Inc. (KROS)](https://www.getswoopr.com/stocks/companies/keros-therapeutics-inc/) | $244 million FY2025 | n/a | 27.7% | 35.7% |
| [Akebia Therapeutics Inc. (AKBA)](https://www.getswoopr.com/stocks/companies/akebia-therapeutics-inc/) | $236 million FY2025 | 47.5% | 9.9% | -2.2% |
| [AnaptysBio Inc. (ANAB)](https://www.getswoopr.com/stocks/companies/anaptysbio-inc/) | $235 million FY2025 | 157.0% | 96.7% | -5.6% |
| [Lifevantage Corporation (LFVN)](https://www.getswoopr.com/stocks/companies/lifevantage-corporation/) | $229 million FY2025 | 14.2% | 5.3% | 4.3% |
| [Puma Biotechnology Inc (PBYI)](https://www.getswoopr.com/stocks/companies/puma-biotechnology-inc/) | $228 million FY2025 | -0.9% | 16.3% | 13.6% |
| [IDEAYA Biosciences Inc. (IDYA)](https://www.getswoopr.com/stocks/companies/ideaya-biosciences-inc/) | $219 million FY2025 | 3024.4% | -72.8% | -52.0% |
| [Vanda Pharmaceuticals Inc. (VNDA)](https://www.getswoopr.com/stocks/companies/vanda-pharmaceuticals-inc/) | $216 million FY2025 | 8.7% | -70.0% | -102.0% |
| [Rhythm Pharmaceuticals Inc. (RYTM)](https://www.getswoopr.com/stocks/companies/rhythm-pharmaceuticals-inc/) | $190 million FY2025 | 45.8% | -101.2% | -0.1% |
| [Maravai LifeSciences Holdings Inc. (MRVI)](https://www.getswoopr.com/stocks/companies/maravai-lifesciences-holdings-inc/) | $186 million FY2025 | -28.3% | -115.9% | -70.4% |
| [Stoke Therapeutics Inc. (STOK)](https://www.getswoopr.com/stocks/companies/stoke-therapeutics-inc/) | $184 million FY2025 | 404.5% | -11.2% | -3.7% |
| [CryoPort Inc. (CYRX)](https://www.getswoopr.com/stocks/companies/cryoport-inc/) | $176 million FY2025 | 12.4% | -20.9% | 44.4% |
| [Phathom Pharmaceuticals Inc. (PHAT)](https://www.getswoopr.com/stocks/companies/phathom-pharmaceuticals-inc/) | $175 million FY2025 | 216.9% | -91.4% | -0.1% |
| [Syndax Pharmaceuticals Inc. (SNDX)](https://www.getswoopr.com/stocks/companies/syndax-pharmaceuticals-inc/) | $172 million FY2025 | 627.8% | -158.4% | -165.6% |
| [Heron Therapeutics Inc. (HRTX)](https://www.getswoopr.com/stocks/companies/heron-therapeutics-inc/) | $155 million FY2025 | 7.4% | -1.6% | -12.9% |
| [MacroGenics Inc. (MGNX)](https://www.getswoopr.com/stocks/companies/macrogenics-inc/) | $150 million FY2025 | -0.3% | -48.7% | -0.0% |
| [Karyopharm Therapeutics Inc. (KPTI)](https://www.getswoopr.com/stocks/companies/karyopharm-therapeutics-inc/) | $146 million FY2025 | 0.6% | -62.1% | -134.2% |
| [Lifecore Biomedical Inc. (LFCR)](https://www.getswoopr.com/stocks/companies/lifecore-biomedical-inc/) | $129 million FY2025 | 0.5% | -13.4% | -30.0% |
| [Gyre Therapeutics Inc. (GYRE)](https://www.getswoopr.com/stocks/companies/gyre-therapeutics-inc/) | $117 million FY2025 | 10.2% | 9.9% | 8.5% |
| [Zevra Therapeutics Inc. (ZVRA)](https://www.getswoopr.com/stocks/companies/zevra-therapeutics-inc/) | $106 million FY2025 | 350.9% | -59.1% | 78.2% |
| [Zymeworks Inc. (ZYME)](https://www.getswoopr.com/stocks/companies/zymeworks-inc/) | $106 million FY2025 | 38.9% | -87.3% | -76.6% |
| [SIGA Technologies Inc. (SIGA)](https://www.getswoopr.com/stocks/companies/siga-technologies-inc/) | $95 million FY2025 | -31.8% | 25.1% | 24.6% |
| [Cytokinetics Incorporated (CYTK)](https://www.getswoopr.com/stocks/companies/cytokinetics-incorporated/) | $88 million FY2025 | 376.6% | -695.4% | -891.6% |
| [Standard BioTools Inc. (LAB)](https://www.getswoopr.com/stocks/companies/standard-biotools-inc/) | $85 million FY2025 | -6.2% | -129.2% | -87.8% |
| [ARS Pharmaceuticals Inc. (SPRY)](https://www.getswoopr.com/stocks/companies/ars-pharmaceuticals-inc/) | $84 million FY2025 | -5.5% | -212.9% | -203.3% |
| [Nurix Therapeutics Inc. (NRIX)](https://www.getswoopr.com/stocks/companies/nurix-therapeutics-inc/) | $84 million FY2025 | 54.0% | -340.2% | -314.9% |
| [Eton Pharmaceuticals Inc. (ETON)](https://www.getswoopr.com/stocks/companies/eton-pharmaceuticals-inc/) | $80 million FY2025 | 104.9% | -1.1% | -5.8% |
| [CytomX Therapeutics Inc. (CTMX)](https://www.getswoopr.com/stocks/companies/cytomx-therapeutics-inc/) | $76 million FY2025 | -44.8% | -29.3% | -22.8% |
| [Assembly Biosciences Inc. (ASMB)](https://www.getswoopr.com/stocks/companies/assembly-biosciences-inc/) | $72 million FY2025 | 153.5% | -16.8% | -8.5% |
| [Viridian Therapeutics Inc. (VRDN)](https://www.getswoopr.com/stocks/companies/viridian-therapeutics-inc/) | $71 million FY2025 | 23359.9% | -512.9% | -483.6% |
| [Rockwell Medical Inc. (RMTI)](https://www.getswoopr.com/stocks/companies/rockwell-medical-inc/) | $69 million FY2025 | -31.8% | -6.8% | -7.7% |
| [Kura Oncology Inc. (KURA)](https://www.getswoopr.com/stocks/companies/kura-oncology-inc/) | $67 million FY2025 | 25.2% | -449.9% | -412.9% |
| [Spero Therapeutics Inc. (SPRO)](https://www.getswoopr.com/stocks/companies/spero-therapeutics-inc/) | $67 million FY2025 | 39.2% | 9.5% | 12.8% |
| [Aytu BioPharma Inc. (AYTU)](https://www.getswoopr.com/stocks/companies/aytu-biopharma-inc/) | $66 million FY2025 | 1.8% | -11.8% | -20.4% |
| [Enanta Pharmaceuticals Inc. (ENTA)](https://www.getswoopr.com/stocks/companies/enanta-pharmaceuticals-inc/) | $65 million FY2025 | -3.4% | -130.7% | -125.4% |
| [Fortress Biotech Inc. (FBIO)](https://www.getswoopr.com/stocks/companies/fortress-biotech-inc/) | $63 million FY2025 | 9.7% | -111.0% | 58.5% |
| [Nuvation Bio Inc. (NUVB)](https://www.getswoopr.com/stocks/companies/nuvation-bio-inc/) | $63 million FY2025 | 699.0% | -338.7% | -325.3% |
| [Tango Therapeutics Inc. (TNGX)](https://www.getswoopr.com/stocks/companies/tango-therapeutics-inc/) | $62 million FY2025 | 48.3% | -178.4% | -162.9% |
| [Journey Medical Corporation (DERM)](https://www.getswoopr.com/stocks/companies/journey-medical-corporation/) | $62 million FY2025 | 10.2% | -13.2% | -18.5% |
| [Nektar Therapeutics (NKTR)](https://www.getswoopr.com/stocks/companies/nektar-therapeutics/) | $55 million FY2025 | -43.9% | -253.7% | -296.9% |
| [Agios Pharmaceuticals Inc. (AGIO)](https://www.getswoopr.com/stocks/companies/agios-pharmaceuticals-inc/) | $54 million FY2025 | 48.0% | -873.9% | -764.4% |
| [Q32 Bio Inc. (QTTB)](https://www.getswoopr.com/stocks/companies/q32-bio-inc/) | $54 million FY2025 | n/a | 31.5% | 55.5% |
| [Ocular Therapeutix Inc. (OCUL)](https://www.getswoopr.com/stocks/companies/ocular-therapeutix-inc/) | $52 million FY2025 | -18.5% | -519.8% | -511.9% |
| [Lexicon Pharmaceuticals Inc. (LXRX)](https://www.getswoopr.com/stocks/companies/lexicon-pharmaceuticals-inc/) | $50 million FY2025 | 60.2% | -98.2% | -101.1% |
| [Gossamer Bio Inc. (GOSS)](https://www.getswoopr.com/stocks/companies/gossamer-bio-inc/) | $48 million FY2025 | -57.7% | -352.2% | -351.5% |
| [Septerna Inc. (SEPN)](https://www.getswoopr.com/stocks/companies/septerna-inc/) | $46 million FY2025 | 4174.5% | -148.6% | -106.4% |
| [Aquestive Therapeutics Inc. (AQST)](https://www.getswoopr.com/stocks/companies/aquestive-therapeutics-inc/) | $45 million FY2025 | -22.6% | -159.5% | -188.1% |
| [Cumberland Pharmaceuticals Inc. (CPIX)](https://www.getswoopr.com/stocks/companies/cumberland-pharmaceuticals-inc/) | $45 million FY2025 | 17.6% | -6.3% | -6.4% |
| [Xilio Therapeutics Inc. (XLO)](https://www.getswoopr.com/stocks/companies/xilio-therapeutics-inc/) | $44 million FY2025 | 589.9% | -95.9% | -80.1% |
| [Palvella Therapeutics Inc. (PVLA)](https://www.getswoopr.com/stocks/companies/palvella-therapeutics-inc/) | $43 million FY2023 | 65.3% | -27.7% | 43.7% |
| [Biofrontera Inc. (BFRI)](https://www.getswoopr.com/stocks/companies/biofrontera-inc/) | $42 million FY2025 | 11.7% | -27.2% | -25.3% |
| [Equillium Inc. (EQ)](https://www.getswoopr.com/stocks/companies/equillium-inc/) | $41 million FY2024 | 13.9% | -20.1% | -19.6% |
| [Verrica Pharmaceuticals Inc. (VRCA)](https://www.getswoopr.com/stocks/companies/verrica-pharmaceuticals-inc/) | $36 million FY2025 | 370.2% | -34.2% | -50.3% |
| [Verastem Inc. (VSTM)](https://www.getswoopr.com/stocks/companies/verastem-inc/) | $31 million FY2025 | 209.1% | -550.3% | -677.6% |
| [Foghorn Therapeutics Inc. (FHTX)](https://www.getswoopr.com/stocks/companies/foghorn-therapeutics-inc/) | $31 million FY2025 | 36.8% | -279.5% | -240.3% |
| [Cue Biopharma Inc. (CUE)](https://www.getswoopr.com/stocks/companies/cue-biopharma-inc/) | $27 million FY2025 | 195.7% | -96.7% | -96.9% |
| [Celularity Inc. (CELU)](https://www.getswoopr.com/stocks/companies/celularity-inc/) | $27 million FY2025 | -51.0% | -230.9% | -345.4% |
| [Entrada Therapeutics Inc. (TRDA)](https://www.getswoopr.com/stocks/companies/entrada-therapeutics-inc/) | $25 million FY2025 | -87.9% | -621.1% | -565.5% |
| [Alumis Inc. (ALMS)](https://www.getswoopr.com/stocks/companies/alumis-inc/) | $24 million FY2025 | n/a | -1886.9% | -1011.7% |
| [SCYNEXIS Inc. (SCYX)](https://www.getswoopr.com/stocks/companies/scynexis-inc/) | $21 million FY2025 | 449.9% | -78.0% | -41.8% |
| [Veru Inc. (VERU)](https://www.getswoopr.com/stocks/companies/veru-inc/) | $17 million FY2024 | 3.6% | -214.2% | -223.9% |
| [Neuphoria Therapeutics Inc. (NEUP)](https://www.getswoopr.com/stocks/companies/neuphoria-therapeutics-inc/) | $16 million FY2025 | n/a | -7.2% | -2.4% |
| [Opus Genetics Inc. (IRD)](https://www.getswoopr.com/stocks/companies/opus-genetics-inc/) | $14 million FY2025 | 29.1% | -271.9% | -349.3% |
| [Pyxis Oncology Inc. (PYXS)](https://www.getswoopr.com/stocks/companies/pyxis-oncology-inc/) | $14 million FY2025 | -14.2% | -609.2% | -574.5% |
| [Tonix Pharmaceuticals Holding Corp. (TNXP)](https://www.getswoopr.com/stocks/companies/tonix-pharmaceuticals-holding-corp/) | $13 million FY2025 | 29.8% | -959.1% | -946.2% |
| [Evommune Inc. (EVMN)](https://www.getswoopr.com/stocks/companies/evommune-inc/) | $13 million FY2025 | 85.7% | -623.6% | -529.8% |
| [Prelude Therapeutics Incorporated (PRLD)](https://www.getswoopr.com/stocks/companies/prelude-therapeutics-incorporated/) | $12 million FY2025 | 73.4% | -861.3% | -819.6% |
| [Jaguar Health Inc. (JAGX)](https://www.getswoopr.com/stocks/companies/jaguar-health-inc/) | $12 million FY2025 | -1.5% | -398.8% | -0.5% |
| [Crescent Biopharma Inc. (CBIO)](https://www.getswoopr.com/stocks/companies/crescent-biopharma-inc/) | $11 million FY2025 | n/a | -1407.5% | 1.4% |
| [Janux Therapeutics Inc. (JANX)](https://www.getswoopr.com/stocks/companies/janux-therapeutics-inc/) | $10 million FY2025 | -5.6% | -1576.7% | -1136.3% |
| [Zenas BioPharma Inc. (ZBIO)](https://www.getswoopr.com/stocks/companies/zenas-biopharma-inc/) | $10 million FY2025 | 100.0% | -3830.6% | -3777.4% |
| [Precigen Inc. (PGEN)](https://www.getswoopr.com/stocks/companies/precigen-inc/) | $10 million FY2025 | 146.7% | -1141.1% | -2587.8% |
| [Prothena Corporation plc (PRTA)](https://www.getswoopr.com/stocks/companies/prothena-corporation-plc/) | $10 million FY2025 | -92.8% | -2216.4% | -2520.6% |
| [BioAge Labs Inc. (BIOA)](https://www.getswoopr.com/stocks/companies/bioage-labs-inc/) | $9 million FY2025 | n/a | -1031.5% | -896.1% |
| [Coya Therapeutics Inc. (COYA)](https://www.getswoopr.com/stocks/companies/coya-therapeutics-inc/) | $8 million FY2025 | 123.6% | -283.9% | -267.1% |
| [Aclaris Therapeutics Inc. (ACRS)](https://www.getswoopr.com/stocks/companies/aclaris-therapeutics-inc/) | $8 million FY2025 | -58.2% | -975.9% | -829.6% |
| [Pulmatrix Inc. (PULM)](https://www.getswoopr.com/stocks/companies/pulmatrix-inc/) | $8 million FY2024 | 7.0% | -125.1% | -122.5% |
| [Bolt Biotherapeutics Inc. (BOLT)](https://www.getswoopr.com/stocks/companies/bolt-biotherapeutics-inc/) | $8 million FY2025 | 0.1% | -469.3% | -433.7% |
| [Ovid Therapeutics Inc. (OVID)](https://www.getswoopr.com/stocks/companies/ovid-therapeutics-inc/) | $7 million FY2025 | 1181.3% | -585.2% | -239.9% |
| [Whitehawk Therapeutics Inc. (WHWK)](https://www.getswoopr.com/stocks/companies/whitehawk-therapeutics-inc/) | $7 million FY2025 | -72.5% | -1601.1% | -288.3% |
| [Tvardi Therapeutics Inc. (TVRD)](https://www.getswoopr.com/stocks/companies/tvardi-therapeutics-inc/) | $7 million FY2024 | -66.0% | -393.8% | -411.9% |
| [Immunome Inc. (IMNM)](https://www.getswoopr.com/stocks/companies/immunome-inc/) | $7 million FY2025 | -23.2% | -3228.8% | -3060.0% |
| [Kyntra Bio Inc. (KYNB)](https://www.getswoopr.com/stocks/companies/kyntra-bio-inc/) | $6 million FY2025 | -78.3% | -712.7% | 2848.6% |
| [Korro Bio Inc. (KRRO)](https://www.getswoopr.com/stocks/companies/korro-bio-inc/) | $6 million FY2025 | 181.5% | -1906.4% | -1834.5% |
| [Abeona Therapeutics Inc. (ABEO)](https://www.getswoopr.com/stocks/companies/abeona-therapeutics-inc/) | $6 million FY2025 | n/a | -1536.9% | -1223.1% |
| [Ensysce Biosciences Inc. (ENSC)](https://www.getswoopr.com/stocks/companies/ensysce-biosciences-inc/) | $5 million FY2025 | -2.8% | -202.1% | -200.8% |
| [CervoMed Inc. (CRVO)](https://www.getswoopr.com/stocks/companies/cervomed-inc/) | $4 million FY2025 | -58.9% | -706.2% | -673.2% |
| [Marker Therapeutics Inc. (MRKR)](https://www.getswoopr.com/stocks/companies/marker-therapeutics-inc/) | $4 million FY2025 | -46.2% | -363.5% | -343.0% |
| [CAMP4 Therapeutics Corporation (CAMP)](https://www.getswoopr.com/stocks/companies/camp4-therapeutics-corporation/) | $3 million FY2025 | 436.5% | -1502.4% | -2298.5% |
| [Aptevo Therapeutics Inc. (APVO)](https://www.getswoopr.com/stocks/companies/aptevo-therapeutics-inc/) | $3 million FY2022 | n/a | -919.7% | 257.8% |
| [TherapeuticsMD Inc. (TXMD)](https://www.getswoopr.com/stocks/companies/therapeuticsmd-inc/) | $3 million FY2025 | 71.6% | -145.3% | -18.8% |
| [Xenetic Biosciences Inc. (XBIO)](https://www.getswoopr.com/stocks/companies/xenetic-biosciences-inc/) | $3 million FY2025 | 19.0% | -95.2% | -90.1% |
| [Upstream Bio Inc. (UPB)](https://www.getswoopr.com/stocks/companies/upstream-bio-inc/) | $3 million FY2025 | 20.4% | -5618.8% | -5026.0% |
| [Cartesian Therapeutics Inc. (RNAC)](https://www.getswoopr.com/stocks/companies/cartesian-therapeutics-inc/) | $3 million FY2025 | -92.8% | -5127.1% | -4658.6% |
| [Traws Pharma Inc. (TRAW)](https://www.getswoopr.com/stocks/companies/traws-pharma-inc/) | $3 million FY2025 | 1134.5% | -640.7% | 328.7% |
| [GeoVax Labs Inc. (GOVX)](https://www.getswoopr.com/stocks/companies/geovax-labs-inc/) | $2 million FY2025 | -37.1% | -869.3% | -862.3% |
| [Elicio Therapeutics Inc. (ELTX)](https://www.getswoopr.com/stocks/companies/elicio-therapeutics-inc/) | $2 million FY2022 | n/a | -1031.4% | -1225.9% |
| [Korsana Biosciences Inc. (KRSA)](https://www.getswoopr.com/stocks/companies/korsana-biosciences-inc/) | $2 million FY2025 | 3.7% | -239.8% | -170.1% |
| [Dianthus Therapeutics Inc. (DNTH)](https://www.getswoopr.com/stocks/companies/dianthus-therapeutics-inc/) | $2 million FY2025 | -67.3% | -8739.3% | -7973.3% |
| [Sagimet Biosciences Inc. (SGMT)](https://www.getswoopr.com/stocks/companies/sagimet-biosciences-inc/) | $2 million FY2023 | n/a | -1537.0% | -1393.8% |
| [Lipocine Inc. (LPCN)](https://www.getswoopr.com/stocks/companies/lipocine-inc/) | $2 million FY2025 | -82.3% | -524.7% | -487.2% |
| [Rani Therapeutics Holdings Inc. (RANI)](https://www.getswoopr.com/stocks/companies/rani-therapeutics-holdings-inc/) | $2 million FY2025 | 58.9% | -2346.0% | -1817.1% |
| [Perspective Therapeutics Inc. (CATX)](https://www.getswoopr.com/stocks/companies/perspective-therapeutics-inc/) | $1 million FY2023 | n/a | -2855.0% | -3243.2% |
| [IGC Pharma Inc. (IGC)](https://www.getswoopr.com/stocks/companies/igc-pharma-inc/) | $1 million FY2025 | -5.5% | -585.8% | -560.3% |
| [Vistagen Therapeutics Inc. (VTGN)](https://www.getswoopr.com/stocks/companies/vistagen-therapeutics-inc/) | $1 million FY2026 | 161.1% | -5683.7% | -5491.9% |
| [NRX Pharmaceuticals Inc. (NRXP)](https://www.getswoopr.com/stocks/companies/nrx-pharmaceuticals-inc/) | $1 million FY2025 | n/a | -1324.4% | -2336.5% |
| [Longeveron Inc. (LGVN)](https://www.getswoopr.com/stocks/companies/longeveron-inc/) | $1 million FY2025 | -49.9% | -1942.2% | -1893.6% |
| [Matinas Biopharma Holdings Inc. (MTNB)](https://www.getswoopr.com/stocks/companies/matinas-biopharma-holdings-inc/) | $1 million FY2023 | -65.6% | -2168.4% | -2093.2% |
| [Dare Bioscience Inc. (DARE)](https://www.getswoopr.com/stocks/companies/dare-bioscience-inc/) | $1 million FY2025 | 10429.4% | -1315.5% | -1300.7% |
| [60 Degrees Pharmaceuticals Inc. (SXTP)](https://www.getswoopr.com/stocks/companies/60-degrees-pharmaceuticals-inc/) | $1 million FY2025 | 65.5% | -771.6% | -732.5% |
| [Shattuck Labs Inc. (STTK)](https://www.getswoopr.com/stocks/companies/shattuck-labs-inc/) | $1 million FY2025 | -82.5% | -5150.8% | -4880.9% |
| [Rafael Holdings Inc. (RFL)](https://www.getswoopr.com/stocks/companies/rafael-holdings-inc/) | $917,000 FY2025 | 44.0% | -3179.8% | -3328.2% |
| [Rallybio Corporation (RLYB)](https://www.getswoopr.com/stocks/companies/rallybio-corporation/) | $858,000 FY2025 | 34.9% | -3853.6% | -1046.4% |
| [Onconetix Inc. (ONCO)](https://www.getswoopr.com/stocks/companies/onconetix-inc/) | $815,371 FY2025 | -67.7% | -2190.0% | -1721.0% |
| [Seres Therapeutics Inc. (MCRB)](https://www.getswoopr.com/stocks/companies/seres-therapeutics-inc/) | $789,000 FY2025 | n/a | -11910.1% | 721.9% |
| [Valion Bio Inc. (VBIO)](https://www.getswoopr.com/stocks/companies/valion-bio-inc/) | $780,000 FY2024 | -33.7% | -573.8% | -725.0% |
| [Unicycive Therapeutics Inc. (UNCY)](https://www.getswoopr.com/stocks/companies/unicycive-therapeutics-inc/) | $675,000 FY2023 | -29.0% | -3077.6% | -4525.0% |
| [PMGC Holdings Inc. (ELAB)](https://www.getswoopr.com/stocks/companies/pmgc-holdings-inc/) | $590,084 FY2025 | n/a | n/a | -1313.0% |
| [Ernexa Therapeutics Inc. (ERNA)](https://www.getswoopr.com/stocks/companies/ernexa-therapeutics-inc/) | $582,000 FY2024 | 755.9% | -2693.1% | -7652.7% |
| [Yarrow Bioscience Inc. (YARW)](https://www.getswoopr.com/stocks/companies/yarrow-bioscience-inc/) | $570,000 FY2025 | 13.8% | -5219.1% | -4646.1% |
| [Imunon Inc. (IMNN)](https://www.getswoopr.com/stocks/companies/imunon-inc/) | $500,000 FY2022 | n/a | -4984.3% | -7179.6% |
| [Pasithea Therapeutics Corp. (KTTA)](https://www.getswoopr.com/stocks/companies/pasithea-therapeutics-corp/) | $486,559 FY2022 | n/a | -2587.3% | -2864.3% |
| [Scienture Holdings Inc. (SCNX)](https://www.getswoopr.com/stocks/companies/scienture-holdings-inc/) | $431,609 FY2025 | 215.9% | -9867.9% | -9618.0% |
| [Medicinova Inc (MNOV)](https://www.getswoopr.com/stocks/companies/medicinova-inc/) | $409,657 FY2025 | n/a | -3242.5% | 2928.8% |
| [iBio Inc. (IBIO)](https://www.getswoopr.com/stocks/companies/ibio-inc/) | $400,000 FY2025 | 77.8% | -4650.5% | -4595.0% |
| [Allarity Therapeutics Inc. (ALLR)](https://www.getswoopr.com/stocks/companies/allarity-therapeutics-inc/) | $320,000 FY2025 | n/a | -3939.1% | -3509.7% |
| [Vyome Holdings Inc. (HIND)](https://www.getswoopr.com/stocks/companies/vyome-holdings-inc/) | $319,714 FY2025 | 24.4% | -3269.4% | -3209.7% |
| [ABVC BioPharma Inc. (ABVC)](https://www.getswoopr.com/stocks/companies/abvc-biopharma-inc/) | $296,000 FY2025 | -41.9% | -2416.0% | -2671.8% |
| [Geron Corporation (GERN)](https://www.getswoopr.com/stocks/companies/geron-corporation/) | $237,000 FY2023 | -60.2% | -81832.9% | -77690.7% |
| [Anixa Biosciences Inc. (ANIX)](https://www.getswoopr.com/stocks/companies/anixa-biosciences-inc/) | $210,000 FY2024 | 0.0% | -6586.2% | -5978.1% |
| [Clene Inc. (CLNN)](https://www.getswoopr.com/stocks/companies/clene-inc/) | $200,000 FY2025 | -41.5% | -11541.5% | -13086.5% |
| [Lisata Therapeutics Inc. (LSTA)](https://www.getswoopr.com/stocks/companies/lisata-therapeutics-inc/) | $170,000 FY2025 | -83.0% | -10711.2% | -10000.0% |
| [Serina Therapeutics Inc. (SER)](https://www.getswoopr.com/stocks/companies/serina-therapeutics-inc/) | $130,000 FY2025 | 132.1% | -18478.5% | -14755.4% |
| [Soligenix Inc. (SNGX)](https://www.getswoopr.com/stocks/companies/soligenix-inc/) | $119,371 FY2024 | -85.8% | -7907.7% | -6953.1% |
| [Bullfrog AI Holdings Inc. (BFRG)](https://www.getswoopr.com/stocks/companies/bullfrog-ai-holdings-inc/) | $116,670 FY2025 | n/a | -5652.4% | -5569.6% |
| [Actinium Pharmaceuticals Inc. (Delaware) (ATNM)](https://www.getswoopr.com/stocks/companies/actinium-pharmaceuticals-inc-delaware/) | $90,000 FY2025 | n/a | -40274.4% | -37652.2% |
| [Citius Pharmaceuticals Inc. (CTXR)](https://www.getswoopr.com/stocks/companies/citius-pharmaceuticals-inc/) | $90,000 FY2022 | n/a | -37017.8% | -37378.5% |
| [Silo Pharma Inc. (SILO)](https://www.getswoopr.com/stocks/companies/silo-pharma-inc/) | $72,102 FY2025 | 0.0% | -5937.0% | -5863.5% |
| [Inovio Pharmaceuticals Inc. (INO)](https://www.getswoopr.com/stocks/companies/inovio-pharmaceuticals-inc/) | $65,343 FY2025 | -70.0% | -132871.3% | -130082.8% |
| [Avalo Therapeutics Inc. (AVTX)](https://www.getswoopr.com/stocks/companies/avalo-therapeutics-inc/) | $59,000 FY2025 | -86.6% | -123601.7% | -132642.4% |
| [Gain Therapeutics Inc. (GANX)](https://www.getswoopr.com/stocks/companies/gain-therapeutics-inc/) | $55,180 FY2023 | -60.6% | -40328.3% | -40354.3% |
| [HCW Biologics Inc. (HCWB)](https://www.getswoopr.com/stocks/companies/hcw-biologics-inc/) | $54,232 FY2025 | -97.9% | -24270.7% | -14677.1% |
| [Altimmune Inc. (ALT)](https://www.getswoopr.com/stocks/companies/altimmune-inc/) | $41,000 FY2025 | 105.0% | -230461.0% | -214861.0% |
| [NeOnc Technologies Holdings Inc. (NTHI)](https://www.getswoopr.com/stocks/companies/neonc-technologies-holdings-inc/) | $39,990 FY2025 | -51.8% | -145637.5% | -155404.4% |
| [Oragenics Inc. (OGEN)](https://www.getswoopr.com/stocks/companies/oragenics-inc/) | $37,653 FY2023 | -71.4% | -55519.9% | -54858.1% |
| [Lyell Immunopharma Inc. (LYEL)](https://www.getswoopr.com/stocks/companies/lyell-immunopharma-inc/) | $36,000 FY2025 | -41.0% | -748344.4% | -762355.6% |
| [Talphera Inc. (TLPH)](https://www.getswoopr.com/stocks/companies/talphera-inc/) | $28,000 FY2025 | n/a | -48157.1% | -51035.7% |
| [Jupiter Neurosciences Inc. (JUNS)](https://www.getswoopr.com/stocks/companies/jupiter-neurosciences-inc/) | $21,796 FY2025 | n/a | -40873.2% | -39662.8% |
| [Genelux Corporation (GNLX)](https://www.getswoopr.com/stocks/companies/genelux-corporation/) | $8,000 FY2025 | 0.0% | -415175.0% | -401812.5% |
| [Aspire-Lakewood Holdings Inc. (ASBP)](https://www.getswoopr.com/stocks/companies/aspire-lakewood-holdings-inc/) | $6,202 FY2025 | n/a | -312016.9% | -394725.1% |
| [Alaunos Therapeutics Inc. (TCRT)](https://www.getswoopr.com/stocks/companies/alaunos-therapeutics-inc/) | $5,000 FY2025 | -50.0% | -84500.0% | -83520.0% |
| [Aardvark Therapeutics Inc. (AARD)](https://www.getswoopr.com/stocks/companies/aardvark-therapeutics-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [ALX Oncology Holdings Inc. (ALXO)](https://www.getswoopr.com/stocks/companies/alx-oncology-holdings-inc/) | $0 FY2022 | n/a | n/a | n/a |
| [Amylyx Pharmaceuticals Inc. (AMLX)](https://www.getswoopr.com/stocks/companies/amylyx-pharmaceuticals-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [Annovis Bio Inc. (ANVS)](https://www.getswoopr.com/stocks/companies/annovis-bio-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Benitec Biopharma Inc. (BNTC)](https://www.getswoopr.com/stocks/companies/benitec-biopharma-inc/) | $0 FY2024 | -100.0% | n/a | n/a |
| [BeyondSpring Inc. (BYSI)](https://www.getswoopr.com/stocks/companies/beyondspring-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Capricor Therapeutics Inc. (CAPR)](https://www.getswoopr.com/stocks/companies/capricor-therapeutics-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [Contineum Therapeutics Inc. (CTNM)](https://www.getswoopr.com/stocks/companies/contineum-therapeutics-inc/) | $0 FY2024 | -100.0% | n/a | n/a |
| [Corbus Pharmaceuticals Holdings Inc. (CRBP)](https://www.getswoopr.com/stocks/companies/corbus-pharmaceuticals-holdings-inc/) | $0 FY2022 | n/a | n/a | n/a |
| [Decoy Therapeutics Inc. (DCOY)](https://www.getswoopr.com/stocks/companies/decoy-therapeutics-inc/) | $0 FY2022 | n/a | n/a | n/a |
| [Design Therapeutics Inc. (DSGN)](https://www.getswoopr.com/stocks/companies/design-therapeutics-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Exicure Inc. (XCUR)](https://www.getswoopr.com/stocks/companies/exicure-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [Fulcrum Therapeutics Inc. (FULC)](https://www.getswoopr.com/stocks/companies/fulcrum-therapeutics-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [Genprex Inc. (GNPX)](https://www.getswoopr.com/stocks/companies/genprex-inc/) | $0 FY2024 | n/a | n/a | n/a |
| [Immuneering Corporation (IMRX)](https://www.getswoopr.com/stocks/companies/immuneering-corporation/) | $0 FY2023 | -100.0% | n/a | n/a |
| [KALA BIO Inc. (KALA)](https://www.getswoopr.com/stocks/companies/kala-bio-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Kiora Pharmaceuticals Inc. (KPRX)](https://www.getswoopr.com/stocks/companies/kiora-pharmaceuticals-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [Lite Strategy Inc. (LITS)](https://www.getswoopr.com/stocks/companies/lite-strategy-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [Minerva Neurosciences Inc (NERV)](https://www.getswoopr.com/stocks/companies/minerva-neurosciences-inc/) | $0 FY2024 | n/a | n/a | n/a |
| [Moleculin Biotech Inc. (MBRX)](https://www.getswoopr.com/stocks/companies/moleculin-biotech-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Monopar Therapeutics Inc. (MNPR)](https://www.getswoopr.com/stocks/companies/monopar-therapeutics-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [NanoViricides Inc. (NNVC)](https://www.getswoopr.com/stocks/companies/nanoviricides-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Nkarta Inc. (NKTX)](https://www.getswoopr.com/stocks/companies/nkarta-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Obsidian Therapeutics Inc. (OBX)](https://www.getswoopr.com/stocks/companies/obsidian-therapeutics-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [OnKure Therapeutics Inc. (OKUR)](https://www.getswoopr.com/stocks/companies/onkure-therapeutics-inc/) | $0 FY2024 | n/a | n/a | n/a |
| [Oruka Therapeutics Inc. (ORKA)](https://www.getswoopr.com/stocks/companies/oruka-therapeutics-inc/) | $0 FY2023 | n/a | n/a | n/a |
| [Palatin Technologies Inc. (PTN)](https://www.getswoopr.com/stocks/companies/palatin-technologies-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [Pliant Therapeutics Inc. (PLRX)](https://www.getswoopr.com/stocks/companies/pliant-therapeutics-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Praxis Precision Medicines Inc. (PRAX)](https://www.getswoopr.com/stocks/companies/praxis-precision-medicines-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [Processa Pharmaceuticals Inc. (PCSA)](https://www.getswoopr.com/stocks/companies/processa-pharmaceuticals-inc/) | $0 FY2022 | n/a | n/a | n/a |
| [Rein Therapeutics Inc. (RNTX)](https://www.getswoopr.com/stocks/companies/rein-therapeutics-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Rocket Pharmaceuticals Inc. (RCKT)](https://www.getswoopr.com/stocks/companies/rocket-pharmaceuticals-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [SELLAS Life Sciences Group Inc. (SLS)](https://www.getswoopr.com/stocks/companies/sellas-life-sciences-group-inc/) | $0 FY2023 | -100.0% | n/a | n/a |
| [Spruce Biosciences Inc. (SPRB)](https://www.getswoopr.com/stocks/companies/spruce-biosciences-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [Spyre Therapeutics Inc. (SYRE)](https://www.getswoopr.com/stocks/companies/spyre-therapeutics-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Summit Therapeutics Inc. (SMMT)](https://www.getswoopr.com/stocks/companies/summit-therapeutics-inc/) | $0 FY2024 | n/a | n/a | n/a |
| [Tenax Therapeutics Inc. (TENX)](https://www.getswoopr.com/stocks/companies/tenax-therapeutics-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [TuHURA Biosciences Inc. (HURA)](https://www.getswoopr.com/stocks/companies/tuhura-biosciences-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [Viking Therapeutics Inc. (VKTX)](https://www.getswoopr.com/stocks/companies/viking-therapeutics-inc/) | $0 FY2025 | n/a | n/a | n/a |
| [vTv Therapeutics Inc. (VTVT)](https://www.getswoopr.com/stocks/companies/vtv-therapeutics-inc/) | $0 FY2025 | -100.0% | n/a | n/a |
| [XBiotech Inc. (XBIT)](https://www.getswoopr.com/stocks/companies/xbiotech-inc/) | $0 FY2023 | -100.0% | n/a | n/a |
| [Zentalis Pharmaceuticals Inc. (ZNTL)](https://www.getswoopr.com/stocks/companies/zentalis-pharmaceuticals-inc/) | $0 FY2025 | -100.0% | n/a | n/a |

Revenue growth compares each company's latest fiscal year with the one before. Fiscal years do not always end on the same date, so treat close comparisons with care.

![Bar chart of operating margin for AbbVie and 7 peers: AbbVie (ABBV) 24.6%, Abbott Laboratories (ABT) 18.2%, Viatris (VTRS) -18.6%, Vertex Pharmaceuticals (VRTX) 34.8%, Alnylam Pharmaceuticals (ALNY) 13.5%, BioMarin Pharmaceutical Inc. (BMRN) 12.7%, United Therapeutics Corporation (UTHR) 46.9%, Royalty Pharma plc (RPRX) 65.6%.](https://www.getswoopr.com/images/charts/abbvie-competitors-peer-margins.webp)
*Operating margin of AbbVie against companies sharing its SEC industry classification, from the table above. Select the chart to open it full size.*

## How Does AbbVie Rank Among All SEC Filers in Its Industry Code?

190 companies with annual reports in Swoopr's SEC dataset share SIC code 2834 (Pharmaceutical Preparations), a wider group than the S&P 500 Equal Weight companies above. Ranks run from 1 (highest) and use each company's latest fiscal year, in U.S. dollars.

| Measure | AbbVie | Median of filers | Rank |
| --- | --- | --- | --- |
| Revenue | $61.2 billion | $27 million | 4 of 190 |
| Revenue growth | 8.6% | 11.1% | 90 of 166 |
| Operating margin | 24.6% | -339.4% | 11 of 182 |
| Net margin | 6.9% | -202.0% | 33 of 190 |

A SIC code reflects the filer's main business as the SEC records it, so the group mixes companies of very different size; the median is a better guide than the average, and a rank near the top by revenue says nothing about quality.

## Where These Numbers Come From

Every figure on this page is a value AbbVie reported in its own SEC filings, read from the SEC's XBRL data (accession 0001551152-26-000008 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.

Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.

## Frequently Asked Questions

### Who are AbbVie's competitors?

Companies sharing AbbVie's SEC classification (SIC code 2834 (Pharmaceutical Preparations)) include Johnson & Johnson (JNJ), Eli Lilly (LLY), Pfizer (PFE), Bristol Myers Squibb (BMY), Abbott Laboratories (ABT). Its 10-K names the competitors it considers most relevant.

### How does AbbVie compare with its peers on margins?

AbbVie's fiscal 2025 operating margin was 24.6%, against a peer median of -340.2%.

### How are these peers chosen?

By the SEC Standard Industrial Classification code each company files under, within Swoopr's S&P 500 Equal Weight company set, falling back to the two-digit major group when fewer than two companies share the exact code. Classification codes are broad, so read the peer list as a screen, not a verdict.

### How does AbbVie rank among all companies in its SEC industry?

Among 190 SEC filers under SIC code 2834, AbbVie ranks 4 by latest revenue, and 11 of 182 by operating margin (24.6% against a median of -339.4%).

## References

- [SEC EDGAR: AbbVie Inc. Form 10-K filed February 20, 2026](https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/abbv-20251231.htm)
- [SEC EDGAR: AbbVie Inc. annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1551152&type=10-K)
- [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces)

## Related Pages

- [AbbVie company dossier](https://www.getswoopr.com/stocks/companies/abbvie/)
- [AbbVie financial metrics](https://www.getswoopr.com/stocks/companies/abbvie/metrics/)
- [AbbVie financial risk indicators](https://www.getswoopr.com/stocks/companies/abbvie/risks/)
- [AbbVie peer comparison](https://www.getswoopr.com/stocks/companies/abbvie/competitors/)
- [AbbVie business model and revenue mix](https://www.getswoopr.com/stocks/companies/abbvie/business-model/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)





**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**



Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).